What Is Testosterone Undecanoate? Half-Life, Dosing Math & How to Track It

What testosterone undecanoate is and how it works

Testosterone undecanoate pairs testosterone with an undecanoate ester — an eleven-carbon chain, far longer than cypionate’s or enanthate’s. A longer carbon chain makes the molecule more oil-soluble and slower to hydrolyze, which is why undecanoate’s depot lasts months, not days.

That length changes the entire delivery model. Cypionate and enanthate come in multi-dose vials you draw a variable volume from every week; injectable undecanoate (Nebido, Aveed) is supplied as a fixed-dose, pre-filled ampule — you don’t titrate the volume, you titrate the interval between injections. A separate oral form (Andriol, Jatenzo) uses the same ester but is absorbed through the intestinal lymphatics rather than depot injection, which is why it needs food and twice-daily dosing despite sharing the same ester name.

The ester is also the heaviest of the common testosterone esters by molecular weight, so a smaller share of each milligram is active hormone: roughly 63% of injectable undecanoate’s mass is testosterone, versus ~70% for cypionate.

Dosing math & the fixed-ampule model

Unlike a compounded TRT vial, injectable testosterone undecanoate doesn’t come in multiple concentrations to choose from — both major brands are formulated at 250 mg/mL, and the whole ampule is given as a single IM injection. The dose is set by the ampule size, not by drawing a custom volume.

The oral form works on totally different math — capsules (typically 40 mg per unit) taken with a fat-containing meal, twice daily, titrated by trough total testosterone rather than by volume at all.

Both brands use the same 250 mg/mL oil solution — only the ampule size differs. Labels call for two loading injections spaced 4–6 weeks apart, then maintenance every 10–14 weeks once trough levels stabilize; the interval, not the volume, is what gets adjusted.

Half-life & what it means for frequency

Injectable undecanoate’s terminal half-life — commonly cited in the 20-to-34-day range in FDA labeling studies — is what allows a quarterly-ish injection schedule instead of a weekly one. Two loading doses close together (typically 4 weeks, sometimes 6) are needed first to reach steady state faster; without them, the first several months would run below target.

The oral capsule form is the opposite story: once absorbed, plasma testosterone from oral undecanoate has a short half-life of only a few hours, which is why it needs twice-daily dosing even though the underlying ester is identical to the ultra-long injectable form. The lymphatic absorption route — not the ester — is what makes oral dosing behave so differently.

What to track & the POME/anaphylaxis warning

The lab panel is the same as any TRT protocol — total and free testosterone, estradiol, hematocrit, and a lipid panel — but trough timing looks different: with injections 10–14 weeks apart, a trough drawn right before the next shot is the only way a number means anything, and levels swing far more slowly than a weekly ester’s.

Injectable undecanoate carries a specific, well-documented safety note worth knowing: a small fraction of injections trigger a pulmonary oil microembolism (POME) reaction — coughing, breathlessness, or fainting shortly after the shot — which is why the injection is given in a clinical setting with a 30-minute observation period afterward. It’s rare, usually self-limited, and the reason this particular ester isn’t self-administered at home the way cypionate or enanthate are.

Frequently asked questions